Is a complete RGC research report available?

No complete published report is available for Regencell Bioscience Holdings Limited (RGC) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Regencell Bioscience Holdings Limited (RGC)

NASDAQ: RGC · USD

$5.65

-0.32 (-5.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first RGC analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	2.8B
Net income (ttm)	-7M
EPS (ttm)	-$0.01
Shares out	495.5M
Volume	174,426
Beta	1.83

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -7M
EPS (ttm): -$0.01
Market cap: 2.8B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All RGC indicators

Market & fundamental data

Available fields

175

Groups with data

Currency

USD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001829667
Company name	Regencell Bioscience Holdings Limited
Country	Hong Kong
Country code	US
Cusip	G7487R100
Employees	10
Employees Change	-2%
Employees Change Percent	-16.67
Enterprise value	$2.8B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	133.1
Industry PE Fwd	14.38
IPO Date	2021-07-16
Isin	KYG7487R1002
Last refreshed	2026-07-30
Market cap	$2.8B
Market cap category	Mid-Cap
Price	$5.65
Price currency	USD
Sector	Healthcare
Sector PE	45.6
Sector PE Fwd	24.3
Sic	2833
Symbol	RGC
Website	https://www.regencellbioscience.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.25%
FCF yield	-0.15%
P/B ratio	2,287.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-7M
Net Income Growth Years	3%
Profit Per Employee	$-704,859
ROA	-84.97
Roa5y	-68.19
ROCE	-529.3
ROE	-177.7
ROIC	-107.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-59.08%
Cagr3y	125.67%
Cagr5y	88.15%
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$3M
Cash	$2.4M
Current Assets	$2.4M
Current Liabilities	$1.7M
Debt	$386,302
Debt Equity	$0.32
Equity	$1.2M
Interest Coverage	-70.1
Liabilities	$1.8M
Long Term Assets	$656,170
Long Term Liabilities	$128,178
Net Cash	$2M
Net Cash By Market Cap	$0.07
Net Cash Growth	-58.94%
Net Debt Equity	$-1.62
Tangible Book Value	$1.2M
Tangible Book Value Per Share	$0
WACC	14.3

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.42
Net Working Capital	$-1.4M
Quick ratio	1.42
Working Capital	$691,391

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-59.06%
200-day SMA	21.24
3Y total return	1,049.98%
50-day SMA	13.56
50-day SMA vs 200-day SMA	50under200
5Y total return	2,256.76%
All Time High	83.6
All Time High Change	-93.24%
All Time High Date	2025-06-16
All Time Low	0.08
All Time Low Change	6,989.08%
All Time Low Date	2024-07-22
ATR	1.1
Beta	1.83
Beta1y	2.84
Beta2y	-1.13
Ch YTD	-73.1
High	6.35
High52	69
High52 Date	2026-01-08
High52ch	-91.81%
Low	5.59
Low52	4.51
Low52 Date	2026-07-17
Low52ch	25.28%
Ma50ch	-58.33%
Premarket Change Percent	-2.51
Premarket Price	$5.82
Premarket Volume	993
Price vs 200-day SMA	-73.4%
RSI	33.53
RSI Monthly	43.05
RSI Weekly	31.47
Sharpe ratio	0.04x
Sortino ratio	0.11
Tr YTD	-73.1
Tr1m	-12.81%
Tr1w	-5.52%
Tr3m	-80.55%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-7.1M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	56,392,450%
Float Percent	11.38%
Shares Insiders	88.62%
Shares Institutions	0.19%
Shares Out	495,474,130
Shares Qo Q	0%
Short Float	1.65%
Short Ratio	1.62
Short Shares	0.19

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-4.4M
Adjusted OCF	-4,246,083
Average Volume	524,433.85x
Bv Per Share	0
CAPEX	$-152,689
Ch1m	-12.81
Ch1w	-5.52
Ch1y	-59.06
Ch3m	-80.55
Ch3y	1,050
Ch5y	2,257.1
Ch6m	-82.5
Change	-5.36%
Change From Open	-5.36
Close	5.97
Days Gap	0
Depreciation Amortization	66,775
Dollar Volume	985,506.9
Earnings Date	2026-05-08
Earnings Time	amc
EBIT	$-7.1M
EBITDA	$-7.1M
EPS	$-0.01
F Score	1
FCF	$-4.2M
FCF EV Yield	-0.15x
FCF Per Share	$-0.01
Fiscal Year End	June
Founded	2,014
Investing CF	4,934,699
Ipr	-40.74
Iprfo	1,682.8
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-08
Last Report Date	2025-12-31
Last Split Date	2025-06-16
Last Split Type	Forward
Last10k Filing Date	2025-10-31
Ma150	23.28
Ma150ch	-75.73%
Ma20	5.8
Ma20ch	-2.55%
Net CF	780,974
Next Earnings Date	2026-10-30
Open	5.97
Optionable	Yes
Position In Range	7.89
Post Close	5.65
Postmarket Change Percent	0.89
Postmarket Price	$5.7
Ppne	562,731
Pre Close	5.97
Price Date	2026-07-29
Ptbv Ratio	2,287.6
Relative Volume	0.33x
Share Based Comp	244,808
Tr6m	-82.5%
Volume	174,426

Regencell Bioscience Holdings Limited (RGC)

Coverage state: Market snapshot only — no published research

Generate the first RGC analysis

Price

Financial snapshot

Fair-value bridge

Latest news · RGC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RGC indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on RGC

Frequently asked questions